KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Capital Expenditures (2016 - 2025)

Exact Sciences (EXAS) has disclosed Capital Expenditures for 16 consecutive years, with -$28.4 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 48.03% to -$28.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75.0 million through Dec 2025, up 66.67% year-over-year, with the annual reading at $75.0 million for FY2025, 66.67% up from the prior year.
  • Capital Expenditures for Q4 2025 was -$28.4 million at Exact Sciences, down from $29.9 million in the prior quarter.
  • The five-year high for Capital Expenditures was $63.3 million in Q2 2022, with the low at -$141.6 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $12.8 million, with a median of $30.5 million recorded in 2025.
  • The sharpest move saw Capital Expenditures soared 175.15% in 2021, then crashed 338.39% in 2022.
  • Over 5 years, Capital Expenditures stood at $59.4 million in 2021, then plummeted by 338.39% to -$141.6 million in 2022, then soared by 37.3% to -$88.8 million in 2023, then skyrocketed by 38.41% to -$54.7 million in 2024, then soared by 48.03% to -$28.4 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at -$28.4 million, $29.9 million, and $42.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.